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ABSTRACT
Objective: Genotoxicity is regarded as one of the potential risk factors for causing pathological diseases. It was confirmed that many chemicals 
have the mutagenic activity which leads to cancer. A compound which interacts with genetic material DNA and shows adverse effects by altering its 
structure or function is referred to as genotoxic.
Aim of the Study: The present research was mainly focused to evaluate genotoxicity profile of classically prepared Jasada Bhasma (JB) by employing 
three crucial genotoxic testing protocols.
Methods: The present study involved 40 Swiss albino mice weighing between 25 and 30 g body weights categorized into four different groups. Group-I 
(normal control) received 0.5% carboxymethyl cellulose as vehicle. Group-II (toxicant control) received 40 mg/kg/body weight cyclophosphamide on 
the 28th day. Group-III and IV received test drug JB 15.6 mg/kg and 78 mg/kg, respectively, for 28 consecutive days. Blood samples were collected and 
processed for evaluating by comet assay. The animals were sacrificed and collected the bone marrow from both the femur for chromosomal aberration 
and micronuclei assay.
Results: JB administered at two different dose levels did not show any significant changes in the comet assay parameters, no micronucleus was found 
and did not produce any chromosomal aberrations both numerically and structurally when compared to positive test control group.
Conclusion: The genotoxicity evaluation of JB did not show any chromosomal aberrations and presence of micronucleus. Thus, the safety data will 
refine therapeutic utility of JB encouraging their rationale use and translate into greater and broader utilization of JB.
Keywords: Jasada Bhasma, Genotoxicity, Comet assay, Chromosomal aberrations.
INTRODUCTION
Zinc is considered as fourth most consumed metal after iron, aluminum, 
and copper. Besides, its widespread use in the industries, it also used in 
health-care products. It is considered an essential trace element and in the 
human growth and development, immunity, and neuronal development, 
zinc has an important role. An adult human body contains 2–3 g of zinc. The 
essential dietary sources are oysters, beef, and peanuts [1,2]. Zinc is used in 
Indian traditional systems of medicine, especially Ayurveda in the form of 
Bhasma. Bhasmas are the ash preparations. They are inorganic preparations 
produced by metals or minerals made into 200–300 nm sized particles by 
conversion into its compounds such as carbonates and oxides prepared 
by the traditional method [3,4]. Jasada Bhasma (JB) is one of the mineral 
based ash formulations. It is highly absorbable due to the decreased particle 
size. It has many therapeutic indications such as immune-modulatory, as 
a supplement in zinc deficiency, and as anti-inflammatory, anti-pyretic, 
antidiabetic, hematinic, and hematogenic agent [5].
According to some experts, there is a need to provide an experimental 
basis for their safety and efficacy. In this background, some studies 
have been done to assess them for toxicity. However, there are a few 
informative data related to the effect at the genetic level. In this study, 
zinc-based JB was assessed for potential genotoxicity considering 
its wide use for the treatment of diseases such as diabetes, anemia, 
ophthalmic disorders, cough, ulcers, and skin diseases [6-10]. A chemical 
which interacts with genetic material DNA and shows adverse effects by 
altering its structure or function is referred to as genotoxic. Most of the 
drugs are genotoxins and produce an irreversible impact on the genetic 
map. Mutagenicity studies by in vivo tests in mammals with a close 
resemblance of metabolism to humans have been reported [11-13]. 
The standard laboratory tests available for genotoxicity evaluation are 
bacterial reverse mutation test (Ames Test), sex-linked recessive lethal 
test in Drosophila melanogaster, Escherichia coli, reverse assay, in vitro 
mammalian chromosome aberration test, in vitro mammalian cell gene 
mutation test, mammalian erythrocyte micronucleus test, mammalian 
bone marrow chromosome aberration test, rodent dominant harmful 
lest, in vitro sister chromatid exchange assay in mammalian cells, 
Saccharomyces cerevisiae, and gene mutation assay [14].
The present study was mainly focused to evaluate genotoxicity profile of 
classically prepared JB by employing three important genotoxic testing 
protocols such as chromosomal aberrations, micronuclear assay, and 
comet assay in Swiss albino mice.
METHODS
The present experimental study was performed using 40 Swiss albino 
mice of both sexes which were obtained from animal house attached to 
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Pharmacology and Toxicology Laboratory at SDM Centre for research 
in Ayurveda and Allied Sciences Udupi, India. The animals were 
acclimatized to standard laboratory conditions such as the temperature 
at 25°C±2°C, humidity of 50–55%, and natural light and dark cycles for 
7 consecutive days before experimentation. Animals were fed with 
commercial pellet diet (Pranav Agro-Industry, Pune) and water ad 
libitum. Institutional Animal Ethical Committee clearance certificate 
was obtained before the experimentation SDMCA/IAEC/CPCEA/
GI04/2011.
Test drug
JB (zinc-based formulation) was used to evaluate the genotoxicity 
potential. Test drug was obtained from a renowned expert in 
Rasashastra (a specialized branch of Ayurveda). The study material was 
obtained from Sri Siddeshwara drugs, Cherpulassery, Palakkad, Kerala, 
batch number of JB drug September 33, 2012.
Experimental design
The study was designed for 28 days with Swiss albino mice weighing 
between 25 and 30 g body weights. Animals were divided into four 
different groups containing 10 mice each. Group-I considered as a 
normal control group and received 0.5% carboxymethyl cellulose as a 
vehicle (CMC). Group-II considered as toxicant control which received 
on the 28th day 40 mg/kg/body weight cyclophosphamide. Group-III 
and IV received test drug JB 15.6 mg/kg and 78 mg/kg, respectively, for 
28 consecutive days.
Dose selection
Dose was derived from human therapeutic dose (TED) by standard 
dose conversion method based on the body surface area ratio proposed 
by Paget and Burns 1969 [10]. Human dose is 120 mg/kg/body weight. 
Two ranges of dose level were selected, TED, and 5 times of TED ×5. On 
this basis, TED was calculated as 15.6 mg/kg/body weight (TED) and 
78 mg/kg/body weight for 5 times of TED ×5. JB suspension was made 
in 0.5% of CMC and orally administered to animals with the help of an 
oral catheter.
Test drug JB was administered for 28 consecutive days. On the 28th-day 
positive control group (Group-II) is received cyclophosphamide at 
a dose of 40 mg/kg by intraperitoneal injection. On 29th-day blood 
samples were collected into heparinized tubes from orbital plexus 
under mild ether anesthesia from all the groups. Peripheral blood 
samples were processed for evaluating by comet assay [8,11,15,16]. On 
the 29th day, after blood was withdrawn from five mice from each group, 
which were injected with colchicine (4 mg/kg IP) to arrest the cells into 
metaphase stage. These animals were sacrificed to collect bone marrow 
from both the femur for chromosomal aberration test. Moreover, rest 
of the animals were also slaughtered and bone marrow harvested for 
micronuclei assay.
Alkaline (ph>13) comet assay
The alkaline (pH>13) comet assay and was carried out according to 
Burlinson et al., 2007, and Hartmann et al., 2003 [8,11]. Briefly, a 10 µL 
aliquot of the suspension containing approximately 10,000 cells was 
mixed with 0.5% low melting point agarose (Sigma) and spread on 
standard microscope slides which were pre-dipped in agarose. On the 
cold surface, the slides were allowed to harden. All the slides were placed 
in cold lysis solution (2.5 M NaCl, 100 mM ethylenediaminetetraacetic 
acid [EDTA], and 10 mM Trizma base, with 1% Triton X-100 (Sigma), 
and 10% dimethyl sulfoxide). Following at least 1–2 h of incubation in 
lysing solution, two slides per sample was rinsed with 0.4 M Trizma 
base and incubated in alkaline conditions (300 mM NaOH, 1 mM EDTA, 
pH>13) for 20 min, followed by electrophoresis in the same buffer for 
30 min at 0.7 V/cm (electrode to electrode) and 300 mA current. After 
electrophoresis to neutralize the alkali, slides were immersed in an 
excess amount of 0.4 M Trizma base and then fixed in 100% ethanol. 
After fixation, the slides were air dried then stained with ethidium 
bromide. The slides were scored without knowledge of the dose group. 
The extent of DNA migration was determined for each sample by 
simultaneous image capture and scoring of 100 cells (50 cells on each 
of two slides) at ×200 magnifications using an imaging system with 
comet assay software. The extent of DNA migration for all samples was 
evaluated according to the following endpoint measurements such as 
percentage tail DNA, tail length, and olive tail moment.
Micronucleus assay
It was carried out by the method suggested by Witt et al., 2008 [15]. The 
bone marrow was aspirated from the shaft of femurs into 5% bovine serum 
albumin (BSA) using 25 gauge needle. The homogeneous suspension 
was made and centrifuged at 1000 rpm for 5 min. The supernatant was 
removed after the centrifugation. With 0.5 ml of 5% BSA, the sediment was 
mixed thoroughly and smeared on a clean slide. Air dried the prepared 
slides and fixed for 5 min in absolute methanol. The air-dried smears 
were first stained with 1:1 diluted May-Grunwald stain using phosphate 
buffer of pH 6.8 for 15 min. Then, the slides were transferred to Giemsa 
stain diluted with phosphate buffer for 10 min. Moreover, slides were 
washed in buffer solution for 5 min. Air-dried slides were observed under 
100X oil immersion objective to score the micronucleated polychromatic 
erythrocytes and micronucleated normochromatic erythrocytes. About 
1000 polychromatic erythrocyte (PCE) and the corresponding number 
of normochromatic erythrocyte (NCE) scored for the presence of 
micronuclei and the determination of PCE/NCE ratio. These ratios were 
used as a measure of the toxicity of test materials. Statistical analysis was 
done to find out the significance of micronucleus induction.
Chromosomal aberration test
It was carried out in bone marrow cells by the method suggested by 
Hayashi, 1992 [16]. Bone marrow cells from both femurs were collected 
and subjected to hypotonic shock (KCl 0.075 M) for about 20 min at 
room temperature. The suspension was centrifuged at 1000 rpm for 
8 min. The cells were fixed with the freshly prepared methanol-acetic 
acid (3:1) fixative for 45 min at room temperature and centrifuged at 
1000 rpm for 8 min. Again the cells were re-suspended in fresh fixative 
for 10 min and centrifuged for 8 min at 1000 rpm. The procedure 
was repeated for 2–3 times. Finally, 0.5 ml of the suspension was 
prepared using fresh fixative. Two to three drops of cell suspension 
were dropped from a distance using Pasteur’s pipette on a clean pre-
chilled glass slide and were dried on the hot plate at 40°C. Then, the 
slides were air dried at room temperature and finally stained with a 5% 
dilution of Giemsa stain in phosphate buffer (pH 6.8) for 30 min. The 
chromosomes of 1000 cells in metaphase were analyzed with a ×100 oil 
immersion objective, using a trinocular microscope. Metaphases with 
chromosomes, chromatid breaks, gaps, rings, stickiness, centric fusion, 
and deletion were recorded.
Statistical analysis
The data were collected and expressed as mean ± SEM and analyzed by 
one-way ANOVA followed by Dunnett’s multiple tests using GraphPad 
InStat version 3.5. p<0.05 was considered statistically significant.
RESULTS
Genotoxic potential of JB analyzed by alkaline (ph>13) comet assay
Cyclophosphamide (40 mg/kg) dose caused significant damage to 
the genetic material by significant increase in the parameters, such 
as comet length, comet height, comet tail length, percentage DNA, 
tail movement, and olive moment as compared to standard control 
(p<0.01). JB administered for 28 consecutive days at two different dose 
levels did not show any significant changes in these parameters, such 
as comet length, comet height, comet tail length, percentage DNA, tail 
movement, and olive moment and values are comparable with that of 
normal control (Table 1 and Fig. 1).
Micronuclei assay
There was a significant increase in the number of micronuclei (MNi) in 
the cyclophosphamide group as compared to normal control (p<0.01). 
The micronucleus was not found at the two dose levels of JB as compared 
cyclophosphamide group, and micronucleus assay did not reveal any 
statistically significant difference between the groups (Table 2 and Fig. 2).
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Chromosomal aberration assay
The bone marrow cells were arrested in the metaphase stage 
and microscopically examined for both numerical and structural 
chromosomal aberrations such as chromosomal gap, chromatid gap, 
exchange, fragments, pulverization, ring, and deletion. It is observed 
that repeated administration of JB at both therapeutic and 5 times 
of dose levels did not produce any chromosomal aberrations both 
numerically and structurally (Table 3 and Fig. 3).
DISCUSSION
Genotoxicity is considered to be one of the potential risk factors 
for causing diseases such as cancer, cardiovascular, aging-related 
disorders, cystic fibrosis, sickle cell anemia, and diabetes. The incidence 
of genotoxicity and mutagenicity is prevailing high in recent years due 
to industrialization, exposure to agricultural pesticides and a wide 
range of chemical substances and radiations. Thus, the regulatory 
authorities have made it mandatory to test any substances for its safety 
profile including genotoxicity and mutagenicity. In the present study, 
a battery of tests such as comet assay, chromosomal aberration tests, 
and micronucleus assay was conducted to evaluate the genotoxicity 
potential of JB.
The toxicant materials cause genotoxicity by direct interaction with 
the genetic materials such as DNA or RNA. This interaction might be 
either with single nucleotide base or a particular location on the DNA 
structure. DNA damage can be assessed based on a number of breakings, 
lesions, fusions, deletions, or mis-segregations in intact DNA. It may 
lead to mutagenesis and causes different malignancies. Oxidative stress 
also plays an important role in the genotoxicity. During the normal 
cellular metabolism, that is, mitochondrial respiratory activity, certain 
amounts of oxidative free radicals are produced, which are effectively 
managed or detoxified by either endogenous or dietary antioxidants. 
However, in case of any chronic or acute exposure to certain cytotoxic 
or noxious chemicals, the endogenous antioxidant fails to detoxify. It 
results in the generation of the enormous amount of reactive oxygen 
species (ROS) such as O2-, OH-, and H2O2. ROS can cause severe oxidative 
lesions in DNA and form 8- hydroxyl deoxyguanosine, which is a potent 
mutagenic lesion [17,18]. Along with genetic material, it can also 
denature biologically essential lipids and protein molecules and leads 
to degenerative diseases such as atherosclerosis, neurodegenerative 
disorders, and cystic fibrosis. Zinc considered being one of the essential 
trace elements, and it is safer only at lower doses; however, it can exert 
system toxicity at higher doses, mainly by deposit in neuronal tissues 
of the brain, and slowly causes cellular damage [19]. The long-term use 
or acute intoxication of zinc interferes with the absorption of copper, 
and hence many of the toxic symptoms are due to copper deficiency 
in the body. It also plays an important role in the cellular apoptosis 
by interfering with the molecular regulators of programmed cell 
death [20]. A study report reveals a boy who has developed lethargy 
and focal neurological deficits after 3 days of 12g of metallic zinc 
ingestion [21]. It has been reported that the zinc oxide nanoparticle 
exerts dose-dependant genotoxicity and cytotoxicity [22].
Comet assay or single cell gel electrophoresis is a simple, inexpensive, 
and more sensitive technique used in the analysis of DNA damage. It 
has wide applications in testing genotoxic potentials of large-scale 
pharmaceutical products, agriculture pesticides, and industrial 
Table 1: Effect of JB on DNA damage in comet assay
Parameters Normal control  (mg/kg) Positive control  (mg/kg) JB 15.6 mg/kg JB  78 mg/kg
Comet length 132±12.98 233.0±12.97** 182.38±25.63 104.77±3.15
Comet height 113±10.94 180.08±9.39** 154±22.04 106.69±4.13
Comet tail length 1.71±0.42 18.75±5.84** 2.91±0.84 6.83±2.19
% DNA 0.82±0.31 22.30±4.64** 5.45±1.41 10.71±3.87
Tail movement 0.0022±0016 6.36±2.15** 0.93±0.64 2.55±1.26
Olive movement 7.30±2.18 19.31±2.04* 6.12±2.24 4.21±1.38
JB: Jasada Bhasma
Table 2: Effect of JB on bone marrow cells in micronuclear test
Group MNPCEs/2000 PCEs
Normal control 1.16±0.65
Cyclophosphamide (40 mg/kg) 60.66±6.86**
JB 15.6 mg/kg 1.66±0.33
JB 78 mg/kg 1.83±0.30
Data expressed in mean ± SEM. *p<0.05, **p<0.01 in comparison 
to normal control. MNPCEs: Micronucleated polychromatic 
erythrocytes, PCE: Polychromatic erythrocyte, JB: Jasada Bhasma
Fig. 1: Photomicrograph of comet assay. (a) NC - normal control, 
(b) CYP - cyclophosphamide, (c) JB (TED) - Jasada Bhasma 




Fig. 2: Photomicrograph of micronucleus assay in bone marrow 
cell smear. (a) NC - normal control, (b) CYP -cyclophosphamide 
control, (c) JB (TED) - Jasada Bhasma therapeutic dose (TED), and 
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chemicals [23]. The single or double strand DNA damage is confirmed 
by fragmented DNA migrated out of the cells nucleolus in the form of a 
characteristic streak similar to the tail of a comet [24]. In the present 
study, the cyclophosphamide drug-treated rat samples showed a 
significant increase in the comet length, comet height, comet tail length, 
percentage DNA, tail movement, and olive movement as compared to 
normal control. The JB treated groups at both dose levels showed no 
significant changes in the comet assay parameters as compared to 
cyclophosphamide group. The changes in DNA profile were almost 
the same as that of normal control, indicating it has no interference 
action with the DNA at both dose levels. Cyclophosphamide is a 
well-known genotoxic and cytotoxic agent. It causes genotoxicity 
by producing highly reactive carbonium ion intermediates which 
transfer the alkyl group to cellular macromolecules. The alkylation 
results in cross-linking or abnormal base pairing or scission of DNA 
strand. Thus, the damaged DNA fragments can be seen as the tail of 
a comet. The micronuclear assay is based on scoring the MNi present 
in the treated cells [25]. Micronuclei are formed during anaphase 
from chromosomal fragments or whole chromosomes that are left 
behind when the nucleus divides. In the current study, administration 
of cyclophosphamide caused a significant increase in the MNi as 
compared to normal control. Repeated administration of JB did not 
cause any substantial changes in the MNi formation as compared to 
cyclophosphamide group. This shows JB at both dose levels does not 
have the potential to induce chromosomal breakage or chromosomal 
gain or loss in bone marrow cells. The purpose of the chromosome 
aberration test is to identify the agents or substances which can 
cause structural mutations in chromosomes or chromatids [26,27]. 
The chromosomal changes such as polyploidy and duplication can 
also be assessed by this test. Thus, any positive test result shows test 
substance possesses potential mutagenic or carcinogenic action in the 
biological system [28]. In the present study, the cyclophosphamide 
administration showed chromosomal and chromatid breaks, gaps, 
and deletions as compared to normal control group, whereas there 
were no changes in the chromosomal and chromatid material in the 
JB administered group as compared to cyclophosphamide group. Thus, 
the test drug has no potential role to cause chromosomal aberration 
when administered at both dose levels.
CONCLUSION
Despite its extensive use, the genotoxicity profile of JB is unexplored. 
In this regard evaluating the genotoxic potential of JB provided 
experimental proof for its safety. In the present study, the genotoxicity 
of JB was assessed by comet assay, micronuclei, and chromosomal 
aberration tests. Results show normal intact DNA and chromosomal 
structure. Thus, providing safety data will refine therapeutic utility of JB 
encouraging their rationale use and translate into higher and broader 
utilization of JB.
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